PEG Microparticles Using Non-Amine Chemistries for Stable Biomolecule Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for coupling proteins and other biomolecules to polyethylene glycol (PEG) microparticles face challenges such as protein precipitation, high protein consumption, rapid hydrolysis of amine-based chemistries, and limited availability of heterobifunctional PEG molecules, leading to unstable and inefficient functionalization.

Innovation Solution

The use of non-amine-based chemistries like sulfhydryl, azide, and alkyne-based chemistries for conjugating biomolecules to PEG microparticles, which are incorporated into the PEG body and allow for stable covalent bonding and extended handling time, avoiding the limitations of amine-based methods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If amine-based chemistries (SCM or succinimidyl valerate groups) are introduced into the PEG mixture for protein coupling, then protein attachment capability is improved, but the groups are rapidly hydrolyzed during microparticle synthesis, resulting in loss of functionality

Engineering Contradiction:
Improveprotein attachment capabilityVSAvoidchemical group stability
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The patent changes the chemical parameters by replacing amine-based reactive groups (SCM, succinimidyl valerate) with non-amine-based groups (maleimide, vinyl sulfone, iodoacetamide, orthopyridyl disulfide). This parameter change maintains protein attachment capability while eliminating rapid hydrolysis, as these non-amine groups are stable in aqueous environments during UV polymerization

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent avoids using transient amine-based functional groups that are rapidly hydrolyzed and lost during synthesis. Instead, it employs stable non-amine groups that persist through the entire microparticle fabrication process, eliminating the need to replenish lost functionality

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If conventional EDC and NHS chemistry is used to couple biomolecules to carboxyl groups on PEG microparticles, then amide bond formation is achieved, but the chemistry is highly sensitive to moisture and requires dry environments, complicating the process

Engineering Contradiction:
Improveamide bond formationVSAvoidmoisture sensitivity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent changes the coupling chemistry parameters by replacing moisture-sensitive EDC/NHS carboxyl-amine coupling with non-amine chemistries (maleimide-thiol, vinyl sulfone-thiol, iodoacetamide-thiol, orthopyridyl disulfide-thiol). These alternative chemistries are not sensitive to moisture and can be performed in aqueous environments, greatly simplifying operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces non-amine reactive groups as intermediary functional groups on the PEG microparticles. These intermediary groups (maleimide, vinyl sulfone, etc.) serve as stable coupling agents that can be incorporated during UV polymerization and later used for reliable biomolecule attachment without moisture sensitivity issues

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If proteins are directly mixed with PEG for functionalization, then protein-PEG conjugation is achieved, but protein precipitation occurs and significant amounts of protein are consumed

Engineering Contradiction:
Improvefunctionalization capabilityVSAvoidprotein loss
Core Design Contradiction:
Adaptability or versatilityVSLoss of substance

Solution Approach 1:

The patent performs preliminary action by incorporating non-amine reactive groups into the PEG matrix during the UV polymerization step, before protein addition. This preliminary functionalization allows subsequent protein coupling under optimized conditions without protein precipitation, as the reactive groups are already embedded in the solid microparticle matrix

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent segments the functionalization process into two distinct steps: (1) incorporation of reactive groups into PEG during UV polymerization to form functionalized microparticles, and (2) subsequent coupling of proteins to these pre-functionalized particles. This segmentation prevents protein-PEG mixing issues and reduces protein loss

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables stable and efficient coupling of biomolecules to PEG microparticles, reducing protein loss and precipitation, and allowing for thorough manipulation and washing, resulting in high-yield, biocompatible, and long-lasting functionalization.

Implementation Method 1

PEG particles are readily formed by UV curing of acrylate functionalized PEG. This involves the use of a photoinitiator with an acrylate functionalized PEG mixture. Exposure to UV leads to the initiation of the reaction and thus the formation of the particles.

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Implementation Method 2

The maleimide group, for example, can be utilized to couple to sulfhydryl groups, which can be introduced cysteines or other thiol groups.

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 3

The PEG-acrylate mixture is then cured with UV to form the particles. The maleimide or other non-amine based chemistry is stable throughout this process and allows time for washing and manipulation of the particles during the coupling steps.

Methodology Applied
Scientific EffectPhotocuring: Photopolymerisation

Data Source

PatentUS9617383B2PEG-based microparticles
Publication Date: 2017.04.11 DNA MEDICINE INST
  • US9617383B2 patent drawing
  • US9617383B2 patent drawing
  • US9617383B2 patent drawing

AI summary

Synthesis of monodisperse PEG-based microparticles with stable coupling chemistries. Biomolecules are conjugated to monodisperse PEG microparticles using non-amine chemistries, such as sulfhydryl groups, azide, or alkyne-based chemistries.